Algae

Photosynthetic organisms that convert CO₂ into biomass and algal oil, which are then further processed into end products for the food, fuel, and chemicals industries.

LUX TAKE:

Algae innovation is now dominated by large corporations following the collapse of the startup space in the mid-2010s; companies initially focused on the fuel industry fast-tracked commercialization with subpar algae to capitalize on the hype, and most failed. The potential of algae now lies within the chemicals and nutrition sectors and is progressing fast. Despite the recent string of failures, ...

Lux Take last updated on September 24, 2019
Data last updated on February 24, 2021

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent algae developments.

News Commentaries

Qualitas Health raises $10 million to expand to the alternative protein market (January 13, 2021)

Algae developer Provectus raises $3.25 million in seed funding (October 20, 2020)

New Lux Content

Water-soluble meets biodegradable: Match made in bio-based heaven or hell? (February 15, 2021)

Navigating Asia's Agrifood Innovation Ecosystem (February 1, 2021)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	OriginClear, Algal Scientific Corporation, Fermentalg, Qualitas Health, AstaReal, T2Energy, SabrTech, Qponics, Euglena, Artveoli, Checkerspot

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978